Stuart Poulton, EVP, Chief Development Officer: Karyopharm Therapeutics KPTI Sell · Filed 24/02/20

Trade details

Type: Insider sale
Amount: $7,644.84
Shares · price: 5,748 sh · $1.33 a share
Held after: 163,871 sh
Stock: Karyopharm Therapeutics KPTI
Person: Stuart PoultonEVP, Chief Development Officer
Trade date: 24/02/15
Filed: 24/02/20
Days to filing: 5 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/16~24/03/16

Stuart Poulton's recent trades

Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,829
403 sh
$3,829
Filed 05/15
Traded 05/14
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$48K
5,101 sh
$48K
Filed 03/03
Traded 03/02
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,262
378 sh
$3,262
Filed 02/19
Traded 02/17
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,578
401 sh
$2,578
Filed 25/09/16
Traded 25/09/15
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$835
191 sh
$835
Filed 25/07/30
Traded 25/07/29

Stuart Poulton, Chief Officer — sold $7,645 of Karyopharm Therapeutics KPTI · 3.4% of holdings | Whalegun